Rankings
▼
Calendar
JANX Q2 2022 Earnings — Janux Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
JANX
Janux Therapeutics, Inc.
$852M
Q2 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+390.7% YoY
Gross Profit
-$12M
-495.6% margin
Operating Income
-$17M
-729.9% margin
Net Income
-$17M
-714.1% margin
EPS (Diluted)
$-0.40
QoQ Revenue Growth
+48.8%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$7M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$385M
Total Liabilities
$42M
Stockholders' Equity
$344M
Cash & Equivalents
$58M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$482,000
+390.7%
Gross Profit
-$12M
-$4M
-175.5%
Operating Income
-$17M
-$6M
-176.1%
Net Income
-$17M
-$6M
-172.1%
← FY 2022
All Quarters
Q3 2022 →